Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Payers

Researchers Explore Organ Recovery and Transplantation Opportunities

Although nearly half of US adults are registered organ donors, transplant waitlists remain long. New research outlines how to accelerate improvement and offers key considerations for payers and regulators.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman

With bid season approaching, payers' pharmacy teams must re-evaluate how to competitively position themselves for success.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Associate, Health and Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

Health plans must maintain a competitive portfolio and double-down on their offerings.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman
Principal, FSA, MAAA, Oliver Wyman

Part 2: Healthcare’s ‘Corona Effect’

Ten expectations regarding voluntary offerings, telemedicine, direct contracting, and more as COVID-19 unfolds.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

We've made big impact over the past ten years. But, our work heading into 2020 and beyond is far from over.

Founder and CEO, Aledade

Insights in your inbox

Subscribe

An analysis of annual premiums by federal poverty level.

Practice Leader, Oliver Wyman Actuarial Consulting

Fourteen percent of physicians offer virtual visits. But a new CMS rule may make telehealth more commonplace.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

We reviewed the approaches State legislators took to offset the effect of defunding CSRs. Here are our observations of activity across the country.

Principal, Oliver Wyman
Practice Leader, Oliver Wyman Actuarial Consulting

Oliver Wyman's analysis of small group market risk adjustment examines past formulas, models, and systems to predict the future.

Practice Leader, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting

Based on our analysis recently featured in the Wall Street Journal, the prevalence of no cost bronze coverage has increased significantly for 2018.

Principal, Oliver Wyman Actuarial Consulting
Practice Leader, Oliver Wyman Actuarial Consulting

Insights in your inbox

Subscribe